S&P 500 7,674.48 −1.07%
Nasdaq 26,157.61 −2.04%
S&P/TSX 35,943.02 −1.05%
Apple 345.71 +0.50%
Nvidia 213.46 −3.83%
Microsoft 526.19 −1.27%
Shopify 239.84 −2.08%
Royal Bank 282.81 −0.29%
CAD/USD 0.7131 +0.31%
LIVE · 12:05 ET
Market ClerkRecap
Thu Oct 22 · markets open6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

BEAM

Beam Therapeutics Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
24.57
−0.27 −1.09%
USD · Oct 22, 12:00 p.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $2.5BP/E —DIV YIELD —FCF YIELD -14.69%REV TTM $156M +158.9%NET INCOME −$85.4MNET CASH $119.6M52W 20.60 – 37.92NEXT EARNINGS Nov 3 EST.SEC XBRL · TTM TO Invalid Date

Congress is trading it

STOCK ACT DISCLOSURES
No STOCK Act disclosure names BEAM.

The STOCK Act allows 45 days to disclose; a lag over that is shown in red. Amounts are the ranges members report. Every member, every trade.

Watch BEAM. Know when insiders buy.
One email the day a filing lands. Free.